Former Chief Medical Officer (7) · Aldeyra Therapeutics, Inc. (ALDX)

David Clark

A named executive officer of Aldeyra Therapeutics in every fiscal year CompBrief holds from FY2017 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$1,971,610

Salary $424,445Stock awards $28,199

FY2018: $1,202,323

3rd of 3 named executive officers at Aldeyra Therapeutics by FY2019 total.

3 named officers on file for Aldeyra Therapeutics, FY2019

David Clark’s pay file — $29

  • 3 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Aldeyra Therapeutics’s whole pay program stands against its peers

  • Aldeyra Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ALDX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2020 (DEF 14A).

Free

Get David Clark’s full pay file as a PDF — free

More than this page: up to 10 years of David’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

David Clark compensation by year

Aldeyra Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Aldeyra Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019
Salary$376,250$424,445$424,445
Bonus$0$0$0
Stock awards$0$0$28,199
Option awards$594,999$644,178$1,359,210
Non-equity incentive$133,525$133,700$148,556
Pension and deferred compensation$0$0$0
All other$0$0$11,200
Total$1,104,774$1,202,323$1,971,610

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Aldeyra Therapeutics, Inc. DEF 14A filed April 27, 2020, accession 0001564590-20-018862, and prior-year filings.

How this page was built: the Aldeyra Therapeutics, Inc. filed document, accession 0001564590-20-018862. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2020.

$1.1M
$1.2M
$2.0M
FY17
FY18
FY19
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
RSU3,503$20,352—
Option192,709—$8.05
Option56,580—$8.60
Option2,131—$6.76
Option42,157—$5.10

Per the Outstanding Equity Awards at Fiscal Year-End table in Aldeyra Therapeutics, Inc.'s FY2019 proxy; value at the fiscal year-end close, as the company printed it.

Aldeyra Therapeutics’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Todd BradyPresident and Chief Executive Officer$4,141,261
Joshua ReedChief Financial Officer$2,181,275
David Clark · this pageFormer Chief Medical Officer (7)$1,971,610

The full Aldeyra Therapeutics compensation record

free company brief

This page is one person within Aldeyra Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Aldeyra Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

David Clark's compensation dossier · One-time report. No refunds.